Clinical Trial Update: Quizartinib or Placebo Plus Chemotherapy in Newly Diagnosed Patients With FLT3-ITD Negative AML [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial compares quizartinib plus chemotherapy to placebo plus chemotherapy in newly diagnosed FLT3-ITD negative acute myeloid leukemia, and th…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• Quizartinib (Quizartinib)

Snippet

Sponsor: Daiichi Sankyo | Conditions: Leukemia | Phase 3 | Status: RECRUITING